Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial |
Jo, Young-Il
(Division of Nephrology, Department of Internal Medicine, Konkuk University Medical Center)
Na, Ha-Young (Division of Nephrology, Department of Internal Medicine, Konkuk University Medical Center) Moon, Ju-Young (Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong) Han, Sang-Woong (Division of Nephrology, Department of Internal Medicine, Hanyang University Guri Hospital) Yang, Dong-Ho (Division of Nephrology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University) Lee, Sang-Ho (Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong) Park, Hyeong-Cheon (Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) Choi, Hoon-Young (Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) Lim, So-Dug (Department of Pathology, Konkuk University Medical Center) Kie, Jeong-Hae (Department of Pathology, National Health Insurance Corporation Ilsan Hospital) Lee, Yong-Kyu (Division of Nephrology, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) Shin, Sug-Kyun (Division of Nephrology, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) |
1 | Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med 2013;368:2402-2414. DOI |
2 | Geddes CC, Rauta V, Gronhagen-Riska C, et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003;18:1541-1548. DOI |
3 | Reich HN, Troyanov S, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007;18:3177-3183. DOI |
4 | Barbour SJ, Reich HN. Risk stratification of patients with IgA nephropathy. Am J Kidney Dis 2012;59:865-873. DOI |
5 | Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005;18:503-512. |
6 | D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004;24:179-196. DOI |
7 | Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 2012;27:1479-1485. DOI |
8 | Gutierrez E, Zamora I, Ballarin JA, et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 2012;23:1753-1760. DOI |
9 | Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534-545. DOI |
10 | Hotta O, Furuta T, Chiba S, Tomioka S, Taguma Y. Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis 2002;39:493-502. DOI |
11 | Li PK, Leung CB, Chow KM, et al. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. Am J Kidney Dis 2006;47:751-760. DOI |
12 | Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 2003;14:1578-1583. DOI |
13 | Cattran DC, Appel GB. Treatment and prognosis of IgA nephropathy [Internet]. UpToDate.com, c2015 [cited 2015 Sep 15]. Available from: http://www.uptodate.com/. |
14 | Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009;361:40-51. DOI |
15 | Appel GB, Waldman M. The IgA nephropathy treatment dilemma. Kidney Int 2006;69:1939-1944. DOI |
16 | Shen P, He L, Huang D. Clinical course and prognostic factors of clinical early IgA nephropathy. Neth J Med 2008;66:242-247. |
17 | Yamamoto R, Imai E. Even partial remission of proteinuria is associated with better renal outcome in patients with IgA nephropathy. Nat Clin Pract Nephrol 2008;4:246-247. |
18 | Bilous R, Chaturvedi N, Sjolie AK, et al. Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med 2009;151:11-20, W3-W4. DOI |
19 | Han SH, Kang EW, Park JK, Kie JH, Han DS, Kang SW. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy. Nephrol Dial Transplant 2011;26:1570-1575. DOI |
20 | Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002;17:1197-1203. DOI |
21 | Szeto CC, Lai FM, To KF, et al. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001;110:434-437. DOI |
22 | Usui J, Yamagata K, Kai H, et al. Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. Intern Med 2001;40:697-702. DOI |
23 | Chapter 10: immunoglobulin A nephropathy. Kidney Int Suppl (2011) 2012;2:209-217. |
24 | Woo KT, Chan CM, Tan HK, et al. Beneficial effects of high-dose losartan in IgA nephritis. Clin Nephrol 2009;71:617-624. DOI |
25 | Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003;139:244-252. DOI |
26 | Horita Y, Tadokoro M, Taura K, et al. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Hypertens Res 2004;27:963-970. DOI |
27 | Tomino Y, Kawamura T, Kimura K, et al. Antiproteinuric effect of olmesartan in patients with IgA nephropathy. J Nephrol 2009;22:224-231. |
28 | Pozzi C, Del Vecchio L, Casartelli D, et al. ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study. J Nephrol 2006;19:508-514. |
29 | Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K. Lowdose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy. Hypertens Res 2008;31:1711-1717. DOI |